4F-MDMB-BICA has been available in the Union since at least March 2020 and has been detected in eleven Member States. 94 seizures in total were reported by eleven Member States [In addition, the United Kingdom reported 17 seizures.]. In addition, one Member State reported a collected sample and one Member State 126 biological samples. 4F-MDMB-BICA in general is likely to be under-detected since the substance is not routinely screened for due to its novelty on the market. In most cases, the substance was seized as powder, in smoking mixtures and as blotters, but it was also identified in liquid form and in other non-specified forms.
Recital 5, Directive (EU) 2021/802
In forcesince 12 Mar 2021